Inhalation toxicity of (1->3)-beta-D glucan: recent advances

Author： Fogelmark Birgitta   Sjostrand Margareta   Williams David   Rylander Ragnar  

Publisher： Informa Healthcare

ISSN： 1466-1861

Source： Mediators of Inflammation, Vol.6, Iss.4, 1997-11, pp. : 263-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocyte activation by (1->3)-beta-D glucans

By Adachi Yoshiyuki   Okazaki Mitsuhiro   Ohno Naohito   Yadomae Toshiro  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 251-256

Informa Healthcare

Access to resources Recommend Favorite

Overview of (1->3)-beta-D-glucan immunobiology

By Williams David L.  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 247-250

Informa Healthcare

Access to resources Recommend Favorite

(1->3)-beta-D-glucan in patients with pulmonary aspergilloma

By Yuasa Kazumi   Goto Hajime  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 285-287

Informa Healthcare

Access to resources Recommend Favorite

Inhalation of (1→3)-β-D-glucan causes airway eosinophilia

By Fogelmark Birgitta   Thorn Jörgen   Rylander Ragnar  

Mediators of Inflammation, Vol. 10, Iss. 1, 2001-02 ,pp. : 13-19

Informa Healthcare

Access to resources Recommend Favorite

Effects after inhalation of (1→3)-β-D-glucan in healthy humans

By Thornca Jörgen   Beijer Lena   Rylander Ragnar  

Mediators of Inflammation, Vol. 10, Iss. 4, 2001-08 ,pp. : 173-178

Informa Healthcare

Access to resources Recommend Favorite